A thrombotic microangiopathy characterized by systemic microvascular platelet aggregation due to failure in degradation of von Willebrand factor (vWF) [1, 15], TTP can predispose patients to both thrombosis and hemorrhage due to marked thrombocytopenia – a relative contraindication to SAC. The gene discussed is VWF; the disease is deep vein thrombosis.